Skip to content

MolADR: Multi-Scale Complementary Learning of Dual-Granularity Molecules and Knowledge Graphs for ADR Prediction in Drug Combinations.

Aug 2026 · Journal of Chemical Information and Modeling · Vol 66 17, pp. 10720-10736 · 0 citations · 40 references
Medicine

TL;DR

MolADR is proposed, a multiscale complementary learning framework that integrates GNN-based KG learning with dual-granularity molecular cross-attention modeling to combine macro-level biomedical associations with microlevel molecular interaction cues, suggesting its ability to highlight chemically plausible atoms and functional groups for organ-level ADR prediction.

Abstract

With the increasing use of multiple medications in clinical practice, accurate and interpretable prediction of organ-level adverse drug reactions (ADRs) induced by drug combinations is essential for drug safety assessment and precision medicine. Existing knowledge graph (KG)-based methods primarily model biomedical associations but leave direct structure-level interactions within drug pairs undercharacterized, while molecular representation methods often rely on whole-molecule or latent substructure encodings, offering limited chemically meaningful evidence for ADR risks. This study proposes MolADR, a multiscale complementary learning framework that integrates GNN-based KG learning with dual-granularity molecular cross-attention modeling to combine macro-level biomedical associations with microlevel molecular interaction cues. Under an emerging-drug setting, MolADR achieves PR-AUC scores of 81.17 ± 3.97, 84.04 ± 4.67, and 74.37 ± 9.90 on three data sets, consistently outperforming state-of-the-art baselines, with further analyses supporting its robustness and suggesting its ability to highlight chemically plausible atoms and functional groups for organ-level ADR prediction.

View source

Similar papers

Aug 2026

A Knowledge Graph–Driven Multimodal Framework for Drug–Disease Association Prediction

KGDDA is proposed, a multimodal framework designed for drug-disease association prediction that synergistically integrates KGs with medical ontologies, enabling the adaptive capture of intricate drug-disease interactions.

Qi-Chang Zhao, Qiao Ling, Muhammad Habibulla Alamin et al. · 0 citations
Aug 2026

A Novel Graph Transformer Framework for Predicting Drug-Disease Associations with Structural Awareness.

SGTL-DDA is proposed, a novel graph transformer framework designed to incorporate structural information and domain-specific knowledge from heterogeneous biological information networks (HBINs) that successfully identifies both known therapeutics and novel repositioning candidates, supported by molecular docking result...

Bowei Zhao, Hui Zhao, Yu-An Huang et al. · 0 citations
Aug 2026

Molecular Fragment-Based Graph Isomorphism Networks for Interpretable Prediction of Synergistic Drug Combinations.

Results indicate that FragSyn, through the synergistic design of fragment-level representation and cellular context awareness, provides an effective and interpretable new approach to synergistic drug combination prediction.

Li-Feng Shao, Jianqiang Sun, Hong-Zhan Ma et al. · 0 citations
Open access Sep 2026

Deciphering Mechanistic Signatures in Drug-Drug Interactions with Dual Topology Graphs

Drug-drug interactions (DDIs) represent a critical challenge in drug development and clinical practice, as they can lead to severe adverse effects, including toxicity and reduced therapeutic efficacy. Deep learning methods have shown promise in large-scale, rapid DDI prediction; however, current approaches suffer from...

Wen-Jian Ma, Xiang-Peng Bi, Hua-Sen Jiang et al. · 0 citations
Aug 2026

MKASynergy: an adaptive method for drug synergy prediction via a mixture-of-experts kernel mechanism

MKASynergy, an adaptive drug synergy prediction method based on a mixture-of-experts kernel mechanism, achieves competitive predictive performance and visualization analysis confirms the model’s effectiveness in feature decoupling and helps interpret latent drug synergistic mechanisms.

Cundong Lin, Jiancheng Ni, Ying Yang et al. · 0 citations
Book Open access Aug 2026

Expanding Knowledge Boundaries via LLM-Grounded Alignment for Drug Combination Recommendation

L2aCo is a model-agnostic knowledge alignment framework that leverages large language models as external biomedical knowledge sources to expand the effective knowledge boundary for drug combinations and substantially improves generalization for cold-start and long-tail cell lines.

Tengfei Ma, Yuqin He, Zhong-Hao Ren et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.